Lorbrena 25 mg/1
lorlatinib · TABLET, FILM COATED · Pfizer Laboratories Div Pfizer Inc
No Recall History
Plain English
Lorbrena is a tablet, film coated containing lorlatinib at 25 mg/1, taken oral. Manufactured by Pfizer Laboratories Div Pfizer Inc.
Key Facts
- Brand Name
- Lorbrena
- Generic Name
- lorlatinib
- NDC Code (Product)
0069-0227- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Strength
- 25 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA210868
- Drug Class
- Kinase Inhibitor [EPC]
- Marketing Start
- 11/19/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is Lorbrena used for?
Lorbrena contains lorlatinib. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is Lorbrena a controlled substance?
Lorbrena is not classified as a controlled substance by the DEA.
What is the generic name for Lorbrena?
The generic name for Lorbrena is lorlatinib. There are no other listed brand versions of lorlatinib.
What is the NDC code for Lorbrena 25 mg/1?
The NDC (National Drug Code) for Lorbrena 25 mg/1 is 0069-0227, listed by Pfizer Laboratories Div Pfizer Inc.
Other Lorbrena Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)